Ramaswamy’s Crypto Policy Calls for Deregulation and Gutting the SEC
Vivek Ramaswamy vows to rescind most federal cryptocurrency regulations and drastically reduce headcount at the Securities and Exchange
2023-11-16 22:52
Poland’s Sudden Surge in Home Prices Is a Risk, Builder Warns
Poland’s home market risks more volatility after a government program to subsidize mortgages triggered an abrupt surge in
2023-11-16 21:53
Schonfeld Cuts 15% of Staff After Exiting Millennium Talks
Schonfeld Strategic Advisors dismissed 15% of its workforce to cut costs after scrapping deal talks with Izzy Englander’s
2023-11-16 21:24
Finland Closes Key Russian Border Crossings
Finland will close four of its busiest border crossings with Russia after concluding that an influx of migrants
2023-11-16 21:17
Walmart Lifts Profit Outlook, Stays Cautious on US Consumers
Walmart Inc. modestly raised its annual profit forecast but struck a cautious tone about the outlook for US
2023-11-16 20:27
Sumitomo Metal Mining looks to boost battery materials output, possibly in US
By Yuka Obayashi TOKYO Japan's Sumitomo Metal Mining is considering producing cathode battery materials in the United States
2023-11-16 19:59
Disco Bonds Surge on Surprise Bank Move to Redeem Them
A group of bonds issued almost 40 years ago by Norwegian lender DNB Bank ASA are surging in
2023-11-16 19:58
Young’s to Buy City Pubs for £162 Million as Bars Suffer
Shares in City Pub Group Plc soared more than 30% after it agreed to a £162 million ($201
2023-11-16 19:47
Vitol Buys BP’s Turkish Gas Stations, Upping Downstream Bet
Vitol’s Petrol Ofisi agreed to buy BP Plc’s gas station operations in Turkey, as the world’s biggest independent
2023-11-16 19:29
Marketmind: Ebbing oil sustains inflation, retail glow
A look at the day ahead in U.S. and global markets from Mike Dolan Ebbing oil prices are cheerleading this
2023-11-16 19:25
Mars to Pay 170% Premium to Take Over Britain’s Hotel Chocolat
Mars Inc., the US candy company, agreed to buy Britain’s Hotel Chocolat Group Plc for £534 million ($662
2023-11-16 18:57
FDA Weighing What to Do About $900,000 Drug That May Not Work
The cancer drug Folotyn, one of the most expensive in the US, received a short-cut approval from US
2023-11-16 18:56